# RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension

> **NCT01756300** · PHASE1 · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 35 (actual)

## Conditions studied

- Hypertension, Renal

## Interventions

- **DEVICE:** Celsius® ThermoCool® RD

## Key facts

- **NCT ID:** NCT01756300
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-11
- **Final completion:** 2015-04
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01756300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01756300, "RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT01756300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*